We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+10.68%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$400B
AUM Growth
+$26.1B
Cap. Flow
-$7.15B
Cap. Flow %
-1.79%
Top 10 Hldgs %
12.04%
Holding
2,531
New
100
Increased
822
Reduced
1,027
Closed
76

Sector Composition

Rank Sector Weight
1 Healthcare 14.66%
2 Consumer Discretionary 13.63%
3 Financials 13.54%
4 Industrials 11.61%
5 Technology 10.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FFIN icon
1926
First Financial Bankshares
FFIN
$5.01B
$435K ﹤0.01%
29,576
CRUS icon
1927
Cirrus Logic
CRUS
$6.11B
$434K ﹤0.01%
19,140
CRK icon
1928
Comstock Resources
CRK
$4.09B
$433K ﹤0.01%
5,448
BGS icon
1929
B&G Foods
BGS
$291M
$432K ﹤0.01%
12,500
CDE icon
1930
Coeur Mining
CDE
$19.3B
$432K ﹤0.01%
35,870
ARNA
1931
DELISTED
Arena Pharmaceuticals Inc
ARNA
$432K ﹤0.01%
8,200
-1,570
-16% -$105K
KERX
1932
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$432K ﹤0.01%
42,800
+24,600
+135% +$219K
ITGR icon
1933
Integer Holdings
ITGR
$4.25B
$430K ﹤0.01%
13,877
SD
1934
DELISTED
SANDRIDGE ENERGY, INC.
SD
$430K ﹤0.01%
73,359
-39,000
-35% -$209K
RPT
1935
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
$428K ﹤0.01%
27,800
-2,000
-7% -$30.7K
CEC
1936
DELISTED
CEC ENTERTAINMENT INC
CEC
$428K ﹤0.01%
9,342
+1,200
+15% +$51.6K
FFBC icon
1937
First Financial Bancorp
FFBC
$3.58B
$427K ﹤0.01%
28,142
-2,000
-7% -$31.4K
HNGR
1938
DELISTED
Hanger Inc.
HNGR
$427K ﹤0.01%
12,650
FURX
1939
DELISTED
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
$427K ﹤0.01%
9,718
-2,100
-18% -$86.9K
BLC
1940
DELISTED
BELO CORP SER A
BLC
$426K ﹤0.01%
31,080
BAC.PRL icon
1941
Bank of America Series L
BAC.PRL
$4.02B
$424K ﹤0.01%
397
VHC icon
1942
VirnetX Holding Corp
VHC
$65.8M
$424K ﹤0.01%
1,040
-160
-13% -$63.1K
CNI icon
1943
Canadian National Railway
CNI
$76.4B
$422K ﹤0.01%
8,320
-800
-9% -$39.5K
NXGN
1944
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$422K ﹤0.01%
19,400
-1,400
-7% -$29.9K
GLF
1945
DELISTED
GulfMark Offshore, Inc. Common Stock
GLF
$422K ﹤0.01%
8,300
+1,100
+15% +$53.9K
GCO icon
1946
Genesco
GCO
$391M
$420K ﹤0.01%
6,400
-3,000
-32% -$205K
KALU icon
1947
Kaiser Aluminum
KALU
$3.1B
$420K ﹤0.01%
5,900
RGR icon
1948
Sturm, Ruger & Co
RGR
$600M
$420K ﹤0.01%
6,700
+500
+8% +$26.9K
BRC icon
1949
Brady Corp
BRC
$4.48B
$418K ﹤0.01%
13,700
SGMO
1950
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$417K ﹤0.01%
39,800

Similar funds

T. Rowe Price Associates's Q3 2013 Portfolio in Review

As of Q3 2013, T. Rowe Price Associates held 2,531 positions worth $400B, up 7% from $374B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

T. Rowe Price Associates's Q3 2013 filing shows 100 new, 822 increased, 1,027 reduced and 76 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 36,580,054 shares worth $1.23B. The largest sale was NEWS CORPORATION CL-A, an estimated $909M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 36,580,054 shares worth $1.23B.
  • T. Rowe Price Associates added most to Apple in Q3 2013, an estimated $742M increase.
  • T. Rowe Price Associates's biggest Q3 2013 reduction was Union Pacific, cutting an estimated $741M.
  • T. Rowe Price Associates fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $909M.
  • T. Rowe Price Associates's ten largest holdings make up 12% of its $400B portfolio in Q3 2013.
  • T. Rowe Price Associates opened 100 new positions and closed 76 in Q3 2013.
  • T. Rowe Price Associates's portfolio value rose 7% quarter-over-quarter to $400B.

Based on T. Rowe Price Associates's 13F filing for Q3 2013, filed 14 Nov 2013.